Why is Dr Reddy's Labs falling/rising?

As of 07-Aug, Dr Reddy's Laboratories Ltd is currently priced at 1,200.75, reflecting an increase of 3.65 (0.3%). Despite this slight uptick, the stock has underperformed its sector by 0.35% today and is trading below its moving averages across various time frames. The stock has experienced a trend reversal, gaining after two consecutive days of decline. Over the past week, Dr Reddy's has seen a return of -5.52%, and year-to-date, it has fallen by 13.51%, indicating a significant underperformance compared to the Sensex, which has gained 3.18% in the same period. The company has a low debt-to-equity ratio and strong long-term fundamentals, with net sales growing at an annual rate of 13.13%. However, recent flat results and a low return on capital employed (ROCE) have raised concerns among investors.
Broader Market Context: In the context of the broader market, Dr Reddy's Laboratories has significantly lagged behind the benchmark, with a one-year return of -13.19% compared to the Sensex's modest gain of 1.45%. This underperformance is compounded by a notable decline in investor participation, as evidenced by a 46.84% drop in delivery volume against the five-day average. Although the stock has high institutional holdings at 63.1%, indicating confidence from larger investors, the overall market sentiment appears cautious, particularly given the company's recent flat financial results and lower profitability metrics.